AI-generated summary
The authors examined LnCap prostate cancer cells in culture, comparing cisplatin at several concentrations with laser light at 610, 630 and 810 nm. Cisplatin reduced cell viability in a dose-dependent manner, while the laser wavelengths showed no notable effect on viability. The study was conducted only in cell culture, so the findings may not apply to humans.
- Who or what was studied
- LnCap prostate cancer cell line (cell culture)
- Wavelengths
- 610, 630, 810 nm
- Limits stated in the abstract
- The study was conducted only in a cell line, without animal or human testing.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
- Energy density (fluence)
- 0.45 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.